Literature DB >> 24510317

A review of the genotoxic and carcinogenic effects of aspartame: does it safe or not?

Serkan Yılmaz1, Aslı Uçar.   

Abstract

The objective of this article is to review genotoxicologic and carcinogenic profile of the artificial sweetener aspartame. Aspartame is a synthetic dipeptide, nearly 180-200 times sweeter than sucrose. It is the most widely used artificial sweetener especially in carbonated and powdered soft drinks, beverages, drugs and hygiene products. There is a discussion ongoing for many years whether aspartame posses genotoxic and carcinogenic risk for humans. This question led to many studies to specify the adverse effects of aspartame. Therefore, we aimed to review the oldest to latest works published in major indices to gather information within this article. With respect to published data, genotoxicity and carcinogenicity of aspartame is still confusing. So, consumers should be aware of the potential side effects of aspartame before they consume it.

Entities:  

Year:  2014        PMID: 24510317      PMCID: PMC4235942          DOI: 10.1007/s10616-013-9681-0

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  30 in total

1.  Aspartame and breast and other cancers.

Authors:  G R Schwartz
Journal:  West J Med       Date:  1999 Nov-Dec

2.  Genotoxicity risk assessment: a proposed classification strategy.

Authors:  Kerry L Dearfield; Michael C Cimino; Nancy E McCarroll; Irving Mauer; Lawrence R Valcovic
Journal:  Mutat Res       Date:  2002-11-26       Impact factor: 2.433

Review 3.  Artificial sweeteners--do they bear a carcinogenic risk?

Authors:  M R Weihrauch; V Diehl
Journal:  Ann Oncol       Date:  2004-10       Impact factor: 32.976

4.  Increasing brain tumor rates: is there a link to aspartame?

Authors:  J W Olney; N B Farber; E Spitznagel; L N Robins
Journal:  J Neuropathol Exp Neurol       Date:  1996-11       Impact factor: 3.685

Review 5.  The potential toxicity of artificial sweeteners.

Authors:  Christina R Whitehouse; Joseph Boullata; Linda A McCauley
Journal:  AAOHN J       Date:  2008-06

6.  Artificial sweeteners and the risk of gastric, pancreatic, and endometrial cancers in Italy.

Authors:  Cristina Bosetti; Silvano Gallus; Renato Talamini; Maurizio Montella; Silvia Franceschi; Eva Negri; Carlo La Vecchia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08       Impact factor: 4.254

7.  In vitro effect of aspartame in angiogenesis induction.

Authors:  Renata Alleva; Battista Borghi; Lory Santarelli; Elisabetta Strafella; Damiano Carbonari; Massimo Bracci; Marco Tomasetti
Journal:  Toxicol In Vitro       Date:  2010-09-17       Impact factor: 3.500

8.  Incidence of brain tumors in rats fed aspartame.

Authors:  H Ishii
Journal:  Toxicol Lett       Date:  1981-03       Impact factor: 4.372

9.  Genotoxicity of aspartame.

Authors:  Eyyüp Rencüzoğullari; Berrin Ayaz Tüylü; Mehmet Topaktaş; Hasan Basri Ila; Ahmet Kayraldiz; Mehmet Arslan; Songül Budak Diler
Journal:  Drug Chem Toxicol       Date:  2004-08       Impact factor: 3.356

10.  Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women.

Authors:  Eva S Schernhammer; Kimberly A Bertrand; Brenda M Birmann; Laura Sampson; Walter C Willett; Diane Feskanich
Journal:  Am J Clin Nutr       Date:  2012-10-24       Impact factor: 8.472

View more
  2 in total

1.  Intake of artificial sweeteners among adults is associated with reduced odds of gastrointestinal luminal cancers: a meta-analysis of cohort and case-control studies.

Authors:  Adam Tepler; Gila Hoffman; Shawn Jindal; Neeraj Narula; Shailja C Shah
Journal:  Nutr Res       Date:  2021-08-01       Impact factor: 3.876

2.  The in vitro cytotoxic, genotoxic, and oxidative damage potentials of the oral artificial sweetener aspartame on cultured human blood cells

Authors:  Kenan Çadirci; Özlem Özdemir Tozlu; Hasan Türkez; Adil Mardinoğlu
Journal:  Turk J Med Sci       Date:  2020-04-09       Impact factor: 0.973

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.